美国急性心肌梗死与心力衰竭死亡率趋势:政策成功还是失败?
该回顾性横断面研究分析了2009至2015年美国2751家(AMI)和3796家(HF)急性护理医院的公开报告死亡率数据,比较基线表现差(2009-2010年最差四分位)与其他医院的30天风险调整死亡率趋势。结果显示,AMI基线差医院死亡率改善更显著,而HF基线差医院略有改善但其他医院死亡率上升,两种疾病趋势明显不同。
要点
- AMI基线差医院30天死亡率从18.6%降至14.6%,年变化-0.74%,改善幅度大于其他医院。
- HF基线差医院死亡率从13.5%降至13.0%,但其他HF医院死亡率从10.9%升至12.0%。
- 尽管政策压力相同,AMI和HF的死亡率趋势在2009至2015年间差异显著。
核心结论
- 在相同的公开报告和价值导向支付政策下,AMI和HF的30天死亡率趋势存在显著差异。
- AMI基线表现差的医院死亡率改善更明显,而HF基线表现差的医院改善有限且其他医院死亡率上升。
研究设计与样本
- 回顾性横断面研究,纳入2009至2015年美国急性护理医院,AMI医院2751家,HF医院3796家。
- 暴露因素为公开报告和价值导向购买政策。
- 主要结局为医院层面风险调整的30天死亡率。
主要发现
- AMI基线差医院(n=422)30天死亡率从2009年18.6%降至2015年14.6%,年变化-0.74%(P<.001);其他医院从15.7%降至14.0%,年变化-0.26%(P<.001);交互P<.001。
- HF基线差医院(n=600)30天死亡率从13.5%降至13.0%,年变化-0.12%(P<.001);其他HF医院从10.9%升至12.0%,年变化0.17%(P<.001);交互P<.001。
- AMI基线差医院更多为公立和营利性医院,较少为教学医院;HF基线差医院较少为大医院。
临床怎么用
- 临床医生应关注AMI和HF死亡率改善的差异,针对HF可能需要额外质量改进策略。
- 公开报告和价值导向支付对AMI效果更明显,对HF可能需结合其他干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hospitals in the United States have been subject to mandatory public reporting of mortality rates for acute myocardial infarction (AMI) and heart failure (HF) since 2007 and to value-based payment programs for these conditions since 2011. However, whether hospitals with initially poor baseline performance have improved relative to other hospitals under these programs, and whether patterns of improvement differ by condition, is unknown. Understanding trends within public reporting and value-based payment can inform future efforts in these areas. OBJECTIVE: To examine patterns in 30-day mortality from AMI and HF and determine whether they differ for baseline poor performers (worst quartile in 2009 and 2010 in public reporting, prior to value-based payment) compared with other hospitals. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cross-sectional study at US acute care hospitals from 2009 to 2015 that included 2751 and 3796 hospitals with publicly reported mortality data for AMI and HF, respectively. EXPOSURES: Public reporting and value-based purchasing. MAIN OUTCOMES AND MEASURES: Hospital-level risk-adjusted 30-day mortality rates. RESULTS: We identified 422 and 600 baseline poor-performing hospitals for AMI and HF, respectively. Baseline poor performers for AMI were more often public and for-profit and less often teaching hospitals. Baseline poor performers for HF were less often large hospitals. For AMI, 30-day mortality among baseline poor performers was higher at baseline but improved more over time compared with other hospitals (18.6% in 2009 to 14.6% in 2015; -0.74% per year; P < .001 vs 15.7% in 2009 to 14.0% in 2015; -0.26% per year; P < .001; P for interaction <.001). In contrast, for HF, baseline poor performers improved over time (13.5%-13.0%; -0.12% per year; P < .001), but mean mortality among all other HF hospitals increased during the study period (10.9%-12.0%; 0.17% per year; P < .001; P for interaction, <.001). CONCLUSIONS AND RELEVANCE: Despite being subject to identical policy pressures, mortality trends for AMI and HF differed markedly between 2009 and 2015.
引用
- Chatterjee P, Joynt Maddox KE. US National Trends in Mortality From Acute Myocardial Infarction and Heart Failure: Policy Success or Failure? JAMA Cardiol. 2018. PMID: 29541764. doi:10.1001/jamacardio.2018.0218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。